
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
Polaris R-Chips in the Frontline Setting in Large Cell Lymphoma?
I'm curious what your perspective is clinically on the Polaris trial. Would you like to use this strategy and if so, in which patients have you been able to do it with it not being approved? Any thoughts? You know, I haven't dipped my toe in the water yet of using Polituzumab R-chip in the frontline setting. But I think that I will be likely an early adopter if it does gain FDA approval from that standpoint.
Transcript
Play full episode